gastro-intestinal bleeding, ascites and hepatopulmonary
syndrome) necessitate liver transplantation in cases where biliary drainage is not effectively established, or surgery not performed.
Variceal hemorrhage, hepatorenal syndrome and hepatopulmonary
syndrome may develop in this syndorme (10).
14) These children appear to be far more prone to developing hepatopulmonary
syndrome (HPS) (14) and may be presented for LT consideration through that pathogenic scenario.
Other chapters address noninvasive exploration of the pulmonary circulation and the right heart; invasive hemodynamic measurements in the management of pulmonary vascular disease; portopulmonary hypertension and hepatopulmonary
syndrome; pulmonary veno-occlusive disease; acute venous thromboembolic disease; atrial septostomy; anticoagulation for venous thromboembolism; and pulmonary vascular disorders in hereditary hemorrhagic telangiectasia.
A Qatari teenager has successfully undergone liver transplant at an Indian hospital after suffering from a condition called hepatopulmonary
syndrome due to congenital hepatic fibrosis (CHF).
Of the 463 patients who underwent initial evaluation for radioembolisation, 63 patients were considered unsuitable, due either to (a) hepatic arterial anatomy that could not be corrected and which could otherwise have led to complications, (b) extensive hepatopulmonary
shunting between the liver and lungs, which raised the potential for excess radiation exposure to the lungs (>30 Gy), or (c) reasons relating to patient consent, such as a preference for another treatment option.
In the case of lung involvement, ERT reverses hepatopulmonary
syndrome and improves pulmonary functional status, and thus reduces dependency on oxygen (18).
We present a cyanotic patient with BCS associating with hepatopulmonary
Evaluation of the protective effects of quercetin in the hepatopulmonary
Named after the Star Wars hero Luke Skywalker, Luke was diagnosed with hepatopulmonary
syndrome, a rare complication of liver disease that causes an abnormal function of the lungs.
The ILTS will fund Michael Ramsay, MD, of Baylor University Medical Center, in Dallas, TX who will speak on Hepatopulmonary
Syndrome and Portopulmonary Hypertension and Critical Aspects of Anesthesia for Liver Transplantation.
Seven papers from authors around the world cover a variety of issues including paediatric transplantation, perioperative care of the living donor and recipient in Japan, the use of recombinant activated factor VII in liver transplantation, portopulmonary hypertension and hepatopulmonary
syndrome, renal failure in end-stage liver disease, supportive care after brain death for the donor candidate, antifibrinolytics, metabolic issues in liver transplantation and immunosuppressive agents.